比亞迪“離奇”騰挪繼續,又有174萬股“移倉”到花旗!
據中證報,比亞迪H股的騰挪仍在繼續。港交所披露數據顯示,繼7月11日花旗銀行席位“離奇”突增約2.25億股比亞迪H股後,截至7月14日,每一天該席位持有的比亞迪H股數量都在增加。7月11日持股量爲388,609,416股,持股比例爲35.39%;7月14日持股量爲390,353,237股,持股比例爲35.55%。3天時間裏,持股量增加了1,743,821股,持股比例提升0.16個百分點。
7月11日2.25億股發生變動時,投資者曾揣測是“股神”巴菲特旗下的伯克希爾·哈撒韋公司減持比亞迪。但港交所的披露易系統並未顯示該公司近期有減持行動,該公司近期也並未發佈相關公告。Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.